Leap Therapeutics, Inc. 52187K200 US52187K2006 07/02/2024 Advisory vote on executive compensation paid to named executive officers ("Say-on-Pay Proposal"). SECTION 14A SAY-ON-PAY VOTES 114355.000000 0 FOR 114355.000000 FOR 1 Avadel Pharmaceuticals Plc G29687103 IE00BDGMC594 07/30/2024 To approve, on a non-binding advisory basis, the compensation of the named executive officers of the Company SECTION 14A SAY-ON-PAY VOTES 333000.000000 0 FOR 333000.000000 FOR 1 Immunovant, Inc. 45258J102 US45258J1025 08/12/2024 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 87815.000000 0 FOR 87815.000000 FOR 1 Roivant Sciences Ltd. G76279101 BMG762791017 09/10/2024 To cast a non-binding, advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 62982.000000 0 FOR 62982.000000 FOR 1 Roivant Sciences Ltd. G76279101 BMG762791017 09/10/2024 To cast a non-binding, advisory vote on the frequency of future non-binding, advisory votes to approve the compensation of our named executive officers every: SECTION 14A SAY-ON-PAY VOTES 62982.000000 0 ONE YEAR 62982.000000 FOR 1 Enstar Group Limited G3075P101 BMG3075P1014 11/06/2024 To approve, on a non-binding, advisory basis, the compensation that will or may become payable by Enstar to its named executive officers in connection with the Mergers. SECTION 14A SAY-ON-PAY VOTES 7500.000000 0 AGAINST 7500.000000 AGAINST 1 Microsoft Corp 594918104 US5949181045 12/10/2024 Advisory Vote to Approve Named Executive Officer Compensation ("say-on-pay vote") SECTION 14A SAY-ON-PAY VOTES 1800 0 FOR 1800 FOR Legacy Housing Corp 52472m101 US52472M1018 12/28/2024 For or against a resolution approving the compensation paid to the Company's named executive officers. This is a non-binding advisory vote and is referred to as a "Say on Pay" vote; SECTION 14A SAY-ON-PAY VOTES 4000 0 FOR 4000 FOR Apple Inc 037833100 US0378331005 02/25/2025 Advisory Vote to Approve Executive Compensation SECTION 14A SAY-ON-PAY VOTES 2100 0 FOR 2100 FOR Dow Inc. 260557103 US2605571031 04/10/2025 Advisory Resolution to Approve Executive Compensation SECTION 14A SAY-ON-PAY VOTES 1206 0 FOR 1206 FOR Broadcom Inc. 11135F101 US11135F1012 04/21/2025 To hold an advisory vote to approve the named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES 710 0 FOR 710 FOR Pfizer Inc. 717081103 US7170811035 04/24/2025 2025 advisory approval of executive compensation SECTION 14A SAY-ON-PAY VOTES 170000.000000 0 AGAINST 170000.000000 AGAINST 1 Verona Pharma Plc 925050106 US9250501064 04/24/2025 To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 112900.000000 0 AGAINST 112900.000000 AGAINST 1 Johnson&Johnson 478160104 US4781601046 04/24/2025 Vote, on an advisory basis, to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES 2766 0 FOR 2766 FOR Pfizer Inc. 717081103 US7170811035 04/24/2025 To conduct an advisory vote to approve our executive compensation. SECTION 14A SAY-ON-PAY VOTES 80 0 FOR 80 FOR Coca-Cola Co. 191216100 US1912161007 04/30/2025 Conduct an advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES 2000 0 FOR 2000 FOR Corteva Inc. 22052L104 US22052L1044 04/30/2025 Advisory resolution to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 11051 0 FOR 11051 FOR aTyr Pharma, Inc. 002120202 US0021202025 05/01/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers; SECTION 14A SAY-ON-PAY VOTES 308133.000000 0 FOR 308133.000000 FOR 1 Kimberly- Clark Corp 494368103 US4943681035 05/01/2025 Approve the compensation for our named executive officers in an advisory vote SECTION 14A SAY-ON-PAY VOTES 6000 0 FOR 6000 FOR Starwood Property Trust 85571B105 US85571B1052 05/01/2025 Approve on an advisory basis the Company's executive compensation SECTION 14A SAY-ON-PAY VOTES 400 0 FOR 400 FOR Occidental Petroleum Corp 674599105 US6745991058 05/02/2025 Approve, on an advisory basis, named executive officer compensation SECTION 14A SAY-ON-PAY VOTES 469 0 FOR 469 FOR Eli Lilly & Co 532457108 US5324571083 05/05/2025 Approval, on an advisory basis, of the compensation paid to the company's named executive officers SECTION 14A SAY-ON-PAY VOTES 300 0 FOR 300 FOR Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Advisory Vote to Approve the Compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES 15000.000000 0 FOR 15000.000000 FOR 1 CSX Corporation 126408103 US1264081035 05/07/2025 Advisory (non-binding) resolution to approve compensation for the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 70000.000000 0 FOR 70000.000000 FOR 1 Ryman Hospitality Properties 78377t107 US78377T1079 05/08/2025 To approve, on an advisory basis, our executive compensation; SECTION 14A SAY-ON-PAY VOTES 12000 0 FOR 12000 FOR United Rentals Inc 911363109 US9113631090 05/08/2025 To approve our executive compensation on an advisory basis; SECTION 14A SAY-ON-PAY VOTES 78 0 FOR 78 FOR AbbVie Inc 00287y109 US00287Y1091 05/09/2025 To vote on an advisory basis on the approval of executive compensation. SECTION 14A SAY-ON-PAY VOTES 5037 0 FOR 5037 FOR Mereo BioPharma Group Plc 589492107 US5894921072 05/13/2025 That the compensation of the Company's named executive officers be approved, on an advisory (non-binding) basis. SECTION 14A SAY-ON-PAY VOTES 319337.000000 0 FOR 319337.000000 FOR 1 Mereo BioPharma Group Plc 589492107 US5894921072 05/13/2025 That the frequency of future advisory votes on the compensation of the Company's named executive officers be approved, on an advisory (non-binding) basis. SECTION 14A SAY-ON-PAY VOTES 319337.000000 0 ONE YEAR 319337.000000 AGAINST 1 International Gaming Tech 459902102 US4599021023 05/13/2025 That the directors' remuneration report (excluding the part containing the directors' remuneration policy) That the directors' remuneration report (excluding the part containing the directors' remuneration policy) for the financial year ended 31 December 2024 set out in the Annual Report and Accounts be approved. SECTION 14A SAY-ON-PAY VOTES 5500 0 FOR 5500 FOR Syndax Pharmaceuticals, Inc. 87164F105 US87164F1057 05/14/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2025 proxy statement. SECTION 14A SAY-ON-PAY VOTES 128000.000000 0 FOR 128000.000000 FOR 1 Vera Therapeutics, Inc. 92337R101 US92337R1014 05/14/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 10000.000000 0 FOR 10000.000000 FOR 1 Vera Therapeutics, Inc. 92337R101 US92337R1014 05/14/2025 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 10000.000000 0 ONE YEAR 10000.000000 FOR 1 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/15/2025 Approval of, on an advisory basis, the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES 38473.000000 0 FOR 38473.000000 FOR 1 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/15/2025 To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES 38473.000000 0 ONE YEAR 38473.000000 FOR 1 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/15/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 228000.000000 0 FOR 228000.000000 FOR 1 Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 05/15/2025 Advisory (non-binding) vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 48000.000000 0 AGAINST 48000.000000 AGAINST 1 Wabtec Corp 929740108 US9297401088 05/15/2025 Approve an advisory (non-binding) resolution to approve the 2024 named executive officer compensation SECTION 14A SAY-ON-PAY VOTES 6 0 FOR 6 FOR AtriCure, Inc. 04963C209 US04963C2098 05/19/2025 Advisory vote on the compensation of our named executive officers as disclosed in the proxy statement for the 2025 Annual Meeting. SECTION 14A SAY-ON-PAY VOTES 19620.000000 0 FOR 19620.000000 FOR 1 AtriCure, Inc. 04963C209 US04963C2098 05/19/2025 Advisory vote on the frequency of future advisory votes on compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 19620.000000 0 ONE YEAR 19620.000000 FOR 1 Eastern Bancshares Inc 27627n105 US27627N1054 05/19/2025 to hold an advisory vote on executive compensation; SECTION 14A SAY-ON-PAY VOTES 5000 0 FOR 5000 FOR Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 05/20/2025 To approve, on an advisory basis, the 2024 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 212000.000000 0 FOR 212000.000000 FOR 1 JP Morgan Chase & Co 46625H100 US46625H1005 05/20/2025 Advisory resolution to approve executive compensation SECTION 14A SAY-ON-PAY VOTES 26185 0 FOR 26185 FOR Amazon 023135106 US0231351067 05/21/2025 Advisory vote to approve executive compensation SECTION 14A SAY-ON-PAY VOTES 900 0 FOR 900 FOR Mondelez Intl 609207105 US6092071058 05/21/2025 To approve, on an advisory basis, the Company's executive compensation SECTION 14A SAY-ON-PAY VOTES 10000 0 FOR 10000 FOR Thermo FisherScientific Inc 883556102 US8835561023 05/21/2025 Approval of an advisory vote on executive compensation SECTION 14A SAY-ON-PAY VOTES 45 0 FOR 45 FOR Dupont De Nemours Inc 26614n102 US26614N1028 05/22/2025 Advisory resolution to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES 9418 0 FOR 9418 FOR FS Bancorp Inc 30263Y104 US30263Y1047 05/22/2025 Advisory (non-binding) approval of the compensation of our named executive officers as disclosed in this proxy statement. SECTION 14A SAY-ON-PAY VOTES 2274 0 FOR 2274 FOR FS Bancorp Inc 30263Y104 US30263Y1047 05/22/2025 Advisory (non-binding) vote on whether future advisory votes on executive compensation should be held every one, two or three years. SECTION 14A SAY-ON-PAY VOTES 2274 0 ONE YEAR 2274 FOR Quanta Services 74762e102 US74762E1029 05/22/2025 Approval, by non-binding advisory vote, of Quanta's executive compensation; SECTION 14A SAY-ON-PAY VOTES 176 0 FOR 176 FOR TotalEnergies SE 89151e109 US89151E1091 05/23/2025 Approval of the information relating to the compensation of executive and non-executive directors ("mandataires sociaux") mentioned in paragraph I of Article L. 22-10-9 of the FrenchCommercial Code SECTION 14A SAY-ON-PAY VOTES 1200 0 FOR 1200 FOR TotalEnergies SE 89151e109 US89151E1091 05/23/2025 Setting of the amount of directors' aggregate annual compensation and approval of the compensation policy of directors SECTION 14A SAY-ON-PAY VOTES 1200 0 FOR 1200 FOR TotalEnergies SE 89151e109 US89151E1091 05/23/2025 Approval of the fixed, variable and extrodanary components making up the total compensation of the chariman and CEO SECTION 14A SAY-ON-PAY VOTES 1200 0 FOR 1200 FOR TotalEnergies SE 89151e109 US89151E1091 05/23/2025 Approval of the compensation policy applicable to the Chairman and CEO SECTION 14A SAY-ON-PAY VOTES 1200 0 FOR 1200 FOR Arcellx, Inc. 03940C100 US03940C1009 05/28/2025 To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement. SECTION 14A SAY-ON-PAY VOTES 15000.000000 0 FOR 15000.000000 FOR 1 Ge Healthcare Technology 36266g107 US36266G1076 05/28/2025 Approval of Our Named Executive Officers' Compensation in an Advisory Vote SECTION 14A SAY-ON-PAY VOTES 50 0 FOR 50 FOR Internationa Business Machines Corp 459200101 US4592001014 05/29/2025 Advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES 2142 0 FOR 2142 FOR United Healthcare Group 91324p102 US91324P1021 06/02/2025 Conduct an advisory vote to approve the compensation paid to the Company's named executive officers as disclosed in the attached proxy statement SECTION 14A SAY-ON-PAY VOTES 57 0 FOR 57 FOR Cogent Biosciences, Inc. 19240Q201 US19240Q2012 06/04/2025 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 269163.000000 0 FOR 269163.000000 FOR 1 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2025 To approve, on an advisory basis, the compensation of the Corporation's named executive officers; SECTION 14A SAY-ON-PAY VOTES 15866.000000 0 FOR 15866.000000 FOR 1 Xeris Biopharma Holdings, Inc. 98422E103 US98422E1038 06/04/2025 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 1060000.000000 0 FOR 1060000.000000 FOR 1 Myriad Genetics, Inc. 62855J104 US62855J1043 06/05/2025 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 160000.000000 0 FOR 160000.000000 FOR 1 Salesforce Inc. 79466l302 US79466L3024 06/05/2025 To approve, on an advisory basis, the fiscal 2025 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 77 0 FOR 77 FOR Tectonic Therapeutic, Inc. 878972108 US8789721086 06/06/2025 Advisory approval of the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES 60000.000000 0 FOR 60000.000000 FOR 1 Tectonic Therapeutic, Inc. 878972108 US8789721086 06/06/2025 Advisory vote on the frequency of stockholder advisory votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES 60000.000000 0 ONE YEAR 60000.000000 FOR 1 Arcus Biosciences, Inc. 03969F109 US03969F1093 06/10/2025 To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 39000.000000 0 FOR 39000.000000 FOR 1 Calumet, Inc. 131428104 US1314281049 06/10/2025 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 1166470.000000 0 FOR 1166470.000000 FOR 1 Calumet, Inc. 131428104 US1314281049 06/10/2025 To vote, on a non-binding, advisory basis, on the frequency of future stockholder advisory votes to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 1166470.000000 0 ONE YEAR 1166470.000000 FOR 1 BioCryst Pharmaceuticals, Inc. 09058V103 US09058V1035 06/12/2025 To hold a non-binding, advisory vote regarding executive compensation. SECTION 14A SAY-ON-PAY VOTES 460000.000000 0 FOR 460000.000000 FOR 1 Solid Biosciences Inc. 83422E204 US83422E2046 06/12/2025 The approval of an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES 132000.000000 0 AGAINST 132000.000000 AGAINST 1 DocGo Inc. 256086109 US2560861096 06/17/2025 To approve on a non-binding, advisory basis the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 3070850.000000 0 AGAINST 3070850.000000 AGAINST 1 Ardelyx, Inc. 039697107 US0396971071 06/18/2025 To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"); SECTION 14A SAY-ON-PAY VOTES 449807.000000 0 FOR 449807.000000 FOR 1 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/20/2025 To cast a non-binding, advisory vote to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 22000.000000 0 AGAINST 22000.000000 AGAINST 1 Protagonist Therapeutics, Inc. 74366E102 US74366E1029 06/20/2025 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 80000.000000 0 FOR 80000.000000 FOR 1 Viridian Therapeutics, Inc. 92790C104 US92790C1045 06/20/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 30000.000000 0 AGAINST 30000.000000 AGAINST 1 NVDIA Corp 67066G104 US67066G1040 06/25/2025 Advisory approval of our executive compensation SECTION 14A SAY-ON-PAY VOTES 2560 0 FOR 2560 FOR Kyndryl Holdings 50155Q100 US50155Q1004 07/31/2025 Approval, in an advisory, non-binding vote, of the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES 428 0 FOR 428 FOR